AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
From AMFI's scheme details and member pages. A dash means AMFI has not published it or it is not loaded, not a zero. AMFI lists fund managers per fund house, not per fund, and reports active SIPs only for the whole industry. The riskometer comes from AMFI's fund performance table, which does not answer automated readers, so it is blank until another source is agreed.
Holdings overlap i
Baroda BNP Paribas Health and Wellness Fund
Aditya Birla Sun Life Business Cycle Fund
Baroda BNP Paribas Health and Wellness Fund
Regular · filing Oct 2026
—
6%
Aditya Birla Sun Life Business Cycle Fund
Regular · filing Oct 2026
6%
—
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Baroda BNP Paribas Health and Wellness Fund and Aditya Birla Sun Life Business Cycle Fund
Overlap
6.2%
smaller weight of each shared stock, added up
Stocks in common
4
of 33 and 57
Weight in common
14% · 8%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stock
Baroda BNP Paribas Health and Wellness Fund
Aditya Birla Sun Life Business Cycle Fund
Counts toward overlap
Torrent Pharmaceuticals Limited
7.74%
2.17%
2.17%
Ajanta Pharma Limited
1.54%
2.23%
1.54%
Fortis Healthcare Limited
4.06%
1.53%
1.53%
Narayana Hrudayalaya Limited
0.96%
1.80%
0.96%
4 stocks
14.3%
7.7%
6.2%
Only in Baroda BNP Paribas Health and Wellness Fund (29)
Sun Pharmaceutical Industries Limited
8.58%
Divi's Laboratories Limited
8.41%
Laurus Labs Limited
7.56%
IPCA Laboratories Limited
6.06%
Lupin Limited
5.86%
Apollo Hospitals Enterprise Limited
5.58%
Glenmark Pharmaceuticals Limited
3.13%
Aurobindo Pharma Limited
2.89%
Dr. Lal Path Labs Limited
2.80%
Zydus Lifesciences Limited
2.45%
AstraZeneca Pharma India Limited
2.40%
Acutaas Chemicals Limited
2.27%
Abbott India Limited
2.15%
Mankind Pharma Limited
2.09%
Aster DM Quality Care Limited
2.00%
Max Financial Services Limited
1.97%
Concord Biotech Limited
1.83%
Symbiotec Pharmalab Ltd
1.59%
Emcure Pharmaceuticals Limited
1.57%
Paras Healthcare Ltd.
1.53%
Dr. Reddy's Laboratories Limited
1.42%
Nephrocare Health Services Limited
1.35%
Gland Pharma Limited
1.30%
Metropolis Healthcare Limited
1.26%
Manipal Health Enterprises Limited
1.19%
and 4 smaller holdings (3.5% of the fund).
Only in Aditya Birla Sun Life Business Cycle Fund (53)
ICICI Bank Limited
4.32%
The Federal Bank Limited
3.55%
Birlasoft Limited
3.16%
Zensar Technologies Limited
2.96%
SHIVALIK BIMETAL CONTROLS LTD
2.79%
Karur Vysya Bank Limited
2.76%
Shaily Engineering Plastics Limited
2.70%
Sai Life Sciences Limited
2.65%
Ather Energy Limited
2.57%
Craftsman Automation Limited
2.53%
TVS Motor Company Limited
2.46%
S.J.S. Enterprises Limited
2.32%
R R Kabel Limited
2.28%
FSN E-Commerce Ventures Limited
2.25%
Vedanta Aluminium Metal Limited
2.05%
Muthoot Finance Limited
2.02%
Jindal Steel Limited
1.97%
JSW Steel Limited
1.90%
Syrma SGS Technology Limited
1.89%
Thyrocare Technologies Limited
1.88%
Mastek Limited
1.79%
CG Power and Industrial Solutions Limited
1.72%
Bank Of Maharashtra
1.71%
Persistent Systems Limited
1.68%
Phoenix Mills Limited
1.65%
and 28 smaller holdings (31.7% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.